These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1186087)

  • 41. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis].
    Vakulenko EF
    Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301
    [No Abstract]   [Full Text] [Related]  

  • 42. [Significance of serum carnitine in patients with liver diseases].
    Lin XH; Jiao LL; Xu GB; Tian GS
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mesenchyma-suppressing therapy of chronic aggressive hepatitis].
    Gros H; Zwirner K; Herzog W
    Med Klin; 1972 Oct; 67(40):1277-82. PubMed ID: 4638147
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of anabolic steroids on protein metabolism under various protein administrations in chronic liver disease patients].
    Blahníková L; Horký J
    Z Ernahrungswiss Suppl; 1972; 13():105-12. PubMed ID: 4510113
    [No Abstract]   [Full Text] [Related]  

  • 45. [Phagocytic activity of the leukocytes in chronic bronchitis].
    Osipov IuA
    Sov Med; 1984; (1):17-21. PubMed ID: 6701647
    [No Abstract]   [Full Text] [Related]  

  • 46. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases].
    Rostomova LT; Kurashvili RB
    Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of chronic active hepatitis by 6-mercaptopurine and immuran (azathioprine)].
    Aprosina ZG; Mukhin AS
    Sov Med; 1972 Feb; 35(2):94-7. PubMed ID: 5039432
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 50. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 51. [Leukocyte intracellular metabolism and phagocytic activity in patients with an erysipelatous inflammation].
    Nagoev BS; Kanukoeva MIu
    Ter Arkh; 1990; 62(11):50-3. PubMed ID: 2094990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anemic syndrome in chronic hepatitis and liver cirrhosis].
    Korolko IuR; Sarycheva TG; Kotelńikov VM; Kozinets GI; Zherebtsov LA
    Klin Med (Mosk); 1993; 71(5):45-8. PubMed ID: 8301986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of prednisolone on the blood coagulation system in chronic hepatitis].
    Krutovskaia OV
    Klin Med (Mosk); 1967 Aug; 45(8):70-3. PubMed ID: 5610475
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 56. Trofopar treatment of chronic liver diseases.
    Loghinov AS; Suhareva GV; Bendikov EA; Blok IE; Astasenkova CJ; Nicolaeva AP
    Rom J Intern Med; 1991; 29(1-2):65-74. PubMed ID: 1947713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Walls WD; Losowsky MS
    Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapeutic use of ornithine-carbamyl-transferase in liver diseases].
    Maccá F; Gatta A; Caregaro L; Lauro S; Milani L; Zuin R; Menozzi L
    Minerva Dietol Gastroenterol; 1982; 28(1):71-8. PubMed ID: 7078779
    [No Abstract]   [Full Text] [Related]  

  • 59. Chronic hepatitis.
    Williams R
    Trans Med Soc Lond; 1968; 84():173-81. PubMed ID: 5708151
    [No Abstract]   [Full Text] [Related]  

  • 60. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.